Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Role of fluorescein angiography guided laser treatment in aggressive retinopathy of prematurity

Abstract

Purpose

To compare disease regression in cases of Fluorescein Angiography (FA) guided laser vs. conventional laser treatment in infants with Aggressive retinopathy of prematurity (AROP).

Methods

60 eyes of 30 infants of AROP were randomized into two groups. In both the group’s FA was done once. Montage of the fundus, FA images was created and the vascular area, avascular areas, and skip areas after laser treatment were demarcated and measured. In group 1, FA-guided laser treatment was done whereas in group 2 they were lasered without seeing FA. Infants were followed up every week to look for skip areas and disease regression.

Results

The mean vascular retinal area in group 1 and group 2 on fundus images was 302.7 sq. mm and 245.8 sq. mm respectively, while the same on FA was 285.2 sq. mm and 221.3 sq. mm respectively, suggesting overestimation of the vascular area on fundus imaging compared to FA which enabled more objective estimation of avascular loop areas. Retinal skip areas in group 1 and group 2 after 1st laser were 18.7 sq. mm and 73.1 sq. mm respectively (P = 0.001), after 2nd laser was 3.7 sq. mm and 19.2 sq. mm (P = 0.003), which suggests FA-guided laser led to significantly fewer skip areas. Infants had regression in 4.1 ± 0.3 wks and 4.2 ± 0.4 wks in groups 1 and 2, respectively.

Conclusion

FA-guided laser ensured lesser skip areas and more complete laser treatment, though regression was similar in both groups.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Combining fundus and FA images to assess laser treatment in group 2.
Fig. 2: Combining fundus and FA images to assess laser treatment in group 1.

Similar content being viewed by others

Data availability

The datasets generated during and/or analysed during the current study are not publicly available due patient privacy but are available from the corresponding author on reasonable request.

References

  1. Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A, et al. International classification of retinopathy of prematurity, Third edition. Ophthalmology 2021; S0161-6420:00416–4.

    Google Scholar 

  2. Kumawat D, Sachan A, Shah P, Chawla R, Chandra P. Aggressive posterior retinopathy of prematurity: a review on current understanding. Eye Lond Engl. 2021;35:1140–58.

    Google Scholar 

  3. Shah PK, Narendran V, Kalpana N. Aggressive posterior retinopathy of prematurity in large preterm babies in South India. Arch Dis Child Fetal Neonatal Ed. 2012;97:F371–375.

    Article  PubMed  Google Scholar 

  4. Stahl A, Lepore D, Fielder A, Fleck B, Reynolds JD, Chiang MF, et al. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet. 2019;394:1551–9.

    Article  Google Scholar 

  5. Sankar MJ, Sankar J, Chandra P. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev. 2018;08:CD009734.

    Google Scholar 

  6. Azad R, Chandra P, Khan MA, Darswal A. Role of intravenous fluorescein angiography in early detection and regression of retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 2008;45:36–9.

    Article  PubMed  Google Scholar 

  7. Yokoi T, Hiraoka M, Miyamoto M, Yokoi T, Kobayashi Y, Nishina S, et al. Vascular abnormalities in aggressive posterior retinopathy of prematurity detected by fluorescein angiography. Ophthalmology 2009;116:1377–82.

    Article  PubMed  Google Scholar 

  8. Shah PK, Prabhu V, Ranjan R, Narendran V, Kalpana N. Retinopathy of prematurity: clinical features, classification, natural history, management and outcome. Indian Pediatr. 2016;53:S118–22.

    PubMed  Google Scholar 

  9. Sanghi G, Dogra MR, Katoch D, Gupta A. Aggressive posterior retinopathy of prematurity in infants ≥1500 g birth weight. Indian J Ophthalmol. 2014;62:254–7.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Sundaram V, Chirla D, Panigrahy N, Kumar P. Current status of NICUs in India: a nationwide survey and the way forward. Indian J Pediatr. 2014;81:1198–204.

    Article  PubMed  Google Scholar 

  11. Ahn SJ, Kim JH, Kim SJ, Yu YS. Capillary-free vascularized retina in patients with aggressive posterior retinopathy of prematurity and late retinal capillary formation. Korean J Opthalmol. 2013;27:109–15.

    Article  Google Scholar 

  12. Axer-Siegel R, Snir M, Cotlear D, Maayan A, Frilling R, Rosenbaltt I, et al. Diode laser treatment of posterior retinopathy of prematurity. Br J Ophthalmol. 2000;84:1383–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Conception or design of the work; or the acquisition, analysis, or interpretation of data for the work. PK PC. Drafting the work or revising it critically for important intellectual content PK PC RA RC RV. Final approval of the version to be published. PK PC RA RC RV. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. PK PC RA RC RV.

Corresponding author

Correspondence to Parijat Chandra.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics

Institutional ethical committee (AIIMS, New Delhi).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kumar, P., Chandra, P., Agarwal, R. et al. Role of fluorescein angiography guided laser treatment in aggressive retinopathy of prematurity. Eye 37, 2130–2134 (2023). https://doi.org/10.1038/s41433-022-02302-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41433-022-02302-0

This article is cited by

Search

Quick links